Six-Month Response to Delamanid Treatment in MDR #TB Patients https://t.co/k6f5iB1l6m MT @CDC_EIDjournal https://t.co/JJjAe1pt18
Six-Month Response to Delamanid Treatment in MDR #TB Patients https://t.co/k6f5iB1l6m MT @CDC_EIDjournal https://t.co/DDbQvqKwhT
Ahead of Print -Six-Month Response to Delamanid Treatment in MDR TB Patients https://t.co/L9rDwgJGWo
RT @MSFsci: Reporting early treatment-response results for the recently available #MDRTB drug, delamanid #DRTB #TB https://t.co/Xkf63OtBeR…
Results show good tolerability and treatment response at 6 months. @m_raviglione @tballiance @paimadhu @globaltb @MSF_access https://t.co/9Skq6H8mCb
RT @MSFsci: Reporting early treatment-response results for the recently available #MDRTB drug, delamanid #DRTB #TB https://t.co/Xkf63OtBeR…
Hope for better outcomes...#MDRTB #DRTB #tb https://t.co/CgB4OKNGZt
RT @MSFsci: Reporting early treatment-response results for the recently available #MDRTB drug, delamanid #DRTB #TB https://t.co/Xkf63OtBeR…
Six-Month Response to Delamanid Treatment in MDR TB Patients via @CDCgov https://t.co/mr0P2qlw7T
6-Month Response to Delamanid in MDR TB - Vol 23, No 10—Oct 2017 - Emerging Infectious Disease- CDC https://t.co/dxqeP457Hb via @CDCgov
.@CDC_EIDjournal: Six-Month Response to Delamanid Treatment in MDR #TB Patients https://t.co/zgFMOw8dtt
Six-Month Response to Delamanid Treatment in MDR TB Patients https://t.co/Enxz5MXD5G